A series of 55 salicylamides, including 3, 5-dibromo-, 5-n-alkyl-, and 5-n-acylsalicyloyl derivatives of various anilines, heterocyclic amines, benzylamines, and alkylamines, was synthesized and evaluated for in vitro antibacterial activity against Actinomyces uiscosus, an adherent oral microorganism implicated in periodontal disease. The in vitro minimum inhibitory concentrations of 15 4'-bromosalicylanilides were found to correlate (r= 0.92) ...
![Benzamide,3,5-dibromo-2-hydroxy-N-[3-(trifluoromethyl)phenyl]结构式](https://image.chemsrc.com/caspic/157/4776-06-1.png)
![Benzamide,3,5-dibromo-N-[(4-chlorophenyl)methyl]-2-hydroxy结构式](https://image.chemsrc.com/caspic/428/20907-42-0.png)
![5-butyl-2-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide结构式](https://image.chemsrc.com/caspic/404/78417-76-2.png)
